// App-Quantinova.ai

Filters

Biomarkers











Conference Name











Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























486 Abstracts

Prognostic value of serum tumor marker (STM) rate of decline during high-dose chemotherapy (HDCT) and peripheral-blood stem-cell transplant (PBSCT) for relapsed germ-cell tumors (rGCT).

Nabil Adra - American Society of Clinical Oncology (ASCO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Molecular profiling by circulating tumor DNA (ctDNA) and benefit from anti-PD-1 in HCC.

Roberto Carmagnani Pestana - American Society of Clinical Oncology (ASCO) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

PROGNOSTIC FACTORS FOR SURVIVAL OF BCLC-C STAGE HEPATOCELLULAR CARCINOMA PATIENTS ACCORDING TO PREVIOUS TREATMENTS: A REAL-LIFE EXPERIENCE

Irene Spinelli - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

FUTILITY OF ULTRASONOGRAPHY AS A SCREENING TOOL FOR HCC IN PATIENTS WAITLISTED FOR LIVER TRANSPLANT. IS IT TIME TO REVISIT SCREENING GUIDELINES FOR HEPATOCELLULAR CARCINOMA?

Bilal Ali - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

THERAPEUTIC EFFICACY OF ANTI-PROGRAMMED CELL DEATH PROTEIN 1 ANTIBODY AND EFFECT OF VITAMIN D SUPPLEMENTATION IN HEPATOCELLULAR CARCINOMA ASSOCIATED WITH B-CATENIN ACTIVATION AND OVER EXPRESSION OF CMET

Mansi Parasramka - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Ergocalciferol

EXPRESSION ANALYSIS OF APOLIPOPROTEIN AI AND AIV IN HEPATOCELLULAR CARCINOMA: A PROTEIN BASED HCC ASSOCIATED STUDY

Dipu Bharali - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

BARRIERS TO HEPATOCELLULAR CARCINOMA (HCC) SURVEILLANCE IN THAILAND

Chonlada Phathong - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

N/A

Alfa-fetoprotein

DETECTION OF EXTRA-COLONIC CANCERS IN SUBJECTS, WHO HAVE CLEAN LARGE BOWEL AT DIAGNOSTIC COLONOSCOPY: APPLICATION OF ORGAN SPECIFIC PLASMA PROTEIN BIOMARKERS

Gerard J. Davis - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Alfa-fetoprotein

ALPHA FETOPROTEIN AND A USEFUL TOOL FOR SURVEILLANCE OF INTERFERON-FREE TREATED CIRRHOTIC PATIENTS FOR HEPATOCELLULAR CARCINOMA AFTER SVR

Speranta Iacob - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

N/A

Interferon

SERUM MONOMERIC LAMININ-332 AS A NOVEL BIOMARKER FOR HEPATOCELLULAR CARCINOMA

Hiroshi Yasuda - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Alfa-fetoprotein

WHICH THERAPEUTIC METHOD SHOULD BE SELECTED IN NON-VIRAL HEPATITIS AND EARLY HEPATOCELLULAR CARCINOMA: RESECTION OR ABLATION? MULTI-CENTER ANALYSIS USING WITH PROPENSITY SCORE MATCHING

Atsushi Hiraoka - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Alfa-fetoprotein

BASELINE CHILD-PUGH AND MELD SCORES PREDICT SUSTAINED NORMALIZATION OF BOTH AST AND ALT IN HCV-INFECTED PATIENTS FOLLOWING DAA INDUCED SVR12

Tung Huynh - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

N/A

N/A

OUTCOMES OF LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA BEYOND THE MILAN CRITERIA: A SYSTEMATIC REVIEW AND META-ANALYSIS

Piyapon Utako - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

MANAGEMENT OF ARTERIO-PORTAL FISTULA-RELATED GASTROESOPHAGEAL VARICEAL BLEEDING

Chengfeng Liu - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

N/A

N/A

ENTERIC GLIAL CELLS (EGCS) IN THE COLONIC MYENTERIC PLEXUS ARE INVOLVED IN ABDOMINAL SURGERY (AS)-INDUCED INHIBITION OF COLONIC PROPULSIVE FUNCTION IN RATS

Yvette Tache - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Acetylcholine

Adding Alpha-Fetoprotein to Ultrasound in Hepatocellular Carcinoma Screening Leads to High Rates of Over-Investigation With Few Additional Diagnoses

Nina Parthasarathy - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

Alfa-fetoprotein

Natural History of Untreated HCC in a U.S. Cohort and the Role of Cancer Surveillance

Jun Ying - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

Sorafenib

Serum Alpha Fetoprotein in Hepatocellular Carcinoma: Effect of Etiology, Race, and Severity of Liver Inflammation

Jianliang Dai - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

The Pattern of Recurrence Associated With the Prognosis of the Patients With Hepatocellular Carcinoma After Radiofrequency Ablation

Kazuhiro Nouso - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

Meta-Analysis: Hepatocellular Carcinoma (HCC) Surveillance Adherence Rate (SAR) in High Risk Patients

Mingjuan Jin - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Liver cancer

N/A

Copyright © 2026. QuantiNova All rights reserved